Creative Planning Regenxbio Inc. Transaction History

Creative Planning

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 05, 2020	SELL	$21.5 - $54.2 $283,800 - $715,440	-13,200 Closed	0 $0
Q4 2019 Jan 30, 2020	SELL	$34.54 - $44.87 $6,908 - $8,974	-200 Reduced 1.49%	13,200 $541,000
Q3 2019 Nov 01, 2019	SELL	$31.84 - $50.88 $7,960 - $12,720	-250 Reduced 1.83%	13,400 $477,000
Q2 2019 Jul 26, 2019	BUY	$42.0 - $59.29 $415,800 - $586,971	9,900 Added 264.0%	13,650 $701,000
Q1 2019 Apr 24, 2019	BUY	$40.82 - $62.45 $153,075 - $234,187	3,750 New	3,750 $215,000
Q4 2018 Feb 01, 2019	SELL	$39.11 - $75.15 $142,751 - $274,297	-3,650 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$65.0 - $82.15 $19,500 - $24,645	-300 Reduced 7.59%	3,650 $276,000
Q2 2018 Jul 20, 2018	BUY	$27.2 - $74.35 $107,440 - $293,682	3,950 New	3,950 $283,000

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $402M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.